We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
COMIRNATY (Pfizer Australia Pty Ltd)
Product name
COMIRNATY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
44 (255 working days)
Active ingredients
SARS-CoV-2 spike protein (mRNA) LP.8.1
Registration type
NCE/ NBE
Indication
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 6 months of age and older.
The use of this vaccine should be in accordance with official recommendations.